Brief: Argent Biopharma Ltd To Delist from London Stock Exchange
29/11/2024 07:05
Nov 29 (Reuters) - London Stock Exchange Group PLC
LSEG.L :
* ARGENT BIOPHARMA LTD - ASX & LSE LISTING UPDATE
* ARGENT BIOPHARMA LTD: NOTICE OF INTENTION TO DELIST FROM
LONDON
STOCK EXCHANGE
* ARGENT BIOPHARMA LTD: WILL MAINTAIN ITS LISTINGS ON ASX
AND
OTCQB VENTURE MARKET
Source text: ID:
Further company coverage: LSEG.L
(Reporting by Tom Wilson)
((T.Wilson@thomsonreuters.com; Reuters Messaging:
t.wilson.thomsonreuters.com@reuters.net))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Brief: Argent Biopharma Files Provisional US Patent On Immune Modulation And Longevity
Australia's Argent BioPharma rises to over 1-month high on new licence agreement
Brief: Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program